Supplementary Figure 2. Expression of Speg in CPCs
qRT-PCR was performed for Speg on RNA extracts from Speg +/+ (white bars) and Speg -/-(black bars) CPCs after culture in medium to retain the cells in an undifferentiated state (-Diff), or in medium to promote cardiomyocyte differentiation (+Diff). Expression levels of Speg mRNA were divided by expression levels of the control gene GAPDH, and shown as a fold change in expression compared with Speg+/+ -Diff. Data are presented as mean ± SEM, n=3 independent experiments per group. * P<0.0001 versus Speg +/+ -Diff, Speg -/--Diff, and Speg -/-+Diff using One-way Analysis of Variance, followed by Newman-Keuls multiple comparison test.
Supplementary Figure 3. Characterization of CPCs
Flow cytometry characterization of Speg +/+ (white bars, cells from a minimum of 3-4 different harvests) and Speg -/-(black bars, cells from a minimum of 2 different harvests) c-kit-positive putative CPCs. (a) Cells were assessed for markers of hematopoietic lineage including CD34, CD133, CD45, CD11b, and CD11c. (b) Cells were assessed for Sca1, and for markers of mesenchymal cells including CD105, CD73, and CD90.2. (c) Cells were assessed for markers of CPC commitment (GATA4), or transcription factors and cytoplasmic markers of cardiomyocyte (NKX2.5, Sar -actin), smooth muscle (GATA6, Calponin), and endothelial (Ets1, CD31, Flk-1) cell lineages. 
Supplementary Figure 5. Exogenous CPCs engraft and differentiate into mature cardiomyocytes in Speg -/-hearts
CPCs were harvested from hearts of C57BL/6-Tg(UBC-GFP)30Scha/J mice and isolated by fluorescence-activated cell sorting (FACS). CPCs were injected in utero at 13.5 dpc into hearts of fetuses from Speg +/-breeding. The hearts were harvested at day 1, and sections from a Speg -/-heart were immunostained for cardiac troponin T (cTnT). 
Supplementary Figure 9. Diastolic assessment of Speg -/-and Speg +/+ hearts after in utero injections of CPCs

Speg
+/+ (white bars, n=6-7/group) and Speg -/-(black bars, n=4-5/group) mice received either no injections (-), or intra-cardiac injections (+) with vehicle (Veh) or CPCs at 13.5 dpc. On day 1 after birth (19.5 dpc), echocardiograms were performed to assess cardiac function. Measurements for thickness of the intraventricular septum (IVS) and LV posterior wall (LVPW), and dimensions of the LV internal diameter (LVID) and LV volume (LV vol) were performed during diastole (d). Data are presented as mean±SEM.
Supplementary Figure 10. Live births of Speg -/-neonates is not improved by injection of mutant CPCs
Fetuses of Speg +/-pregnant dams were injected with either wild-type CPCs (+/+, n=6 litters) or mutant CPCs (-/-, n=5 litters) at 13.5 dpc. On day 1 after birth (19.5 dpc), percent of live births were assessed in Speg +/+ (white bars) and Speg -/-(black bars) pups (left panel). P=0.0291; † versus Speg -/-pups, wild-type CPCs injection using Fisher's exact test. In the right panel, fold change (mean ±SEM) in live births of Speg -/-pups receiving either wild-type (+/+) or mutant (-/-) CPCs. P=0.0262; † versus Speg -/-pups, +/+ CPCs injection using Student's unpaired t test. 
